Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Retained Earnings (2017 - 2021)

Cogent Biosciences has reported Retained Earnings over the past 5 years, most recently at -$246.1 million for Q3 2021.

  • Quarterly results put Retained Earnings at -$246.1 million for Q3 2021, down 31.33% from a year ago — trailing twelve months through Sep 2021 was -$246.1 million (down 31.33% YoY), and the annual figure for FY2020 was -$198.7 million, down 60.38%.
  • Retained Earnings for Q3 2021 was -$246.1 million at Cogent Biosciences, down from -$227.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for COGT hit a ceiling of -$2000.0 in Q1 2019 and a floor of -$246.1 million in Q3 2021.
  • Median Retained Earnings over the past 5 years was -$125.0 million (2019), compared with a mean of -$114.8 million.
  • Biggest five-year swings in Retained Earnings: soared 99.98% in 2018 and later plummeted 6499200.0% in 2020.
  • Cogent Biosciences' Retained Earnings stood at -$51.3 million in 2017, then soared by 99.98% to -$12000.0 in 2018, then tumbled by 1032333.33% to -$123.9 million in 2019, then tumbled by 60.38% to -$198.7 million in 2020, then decreased by 23.84% to -$246.1 million in 2021.
  • The last three reported values for Retained Earnings were -$246.1 million (Q3 2021), -$227.0 million (Q2 2021), and -$210.4 million (Q1 2021) per Business Quant data.